Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Narod

Showing results (261-270 of 544) with videos related to

Pageof 55
Sort By:
Breast Cancer Research and Treatment|November 26, 2008
Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer riskPablo Serrano-Fernández, Tadeusz Debniak, Bohdan Górski, et al.
Plos One|June 16, 2009
Polymorphic variation of genes in the fibrinolytic system and the risk of ovarian cancerYaakov Bentov, Theodore J Brown, Mohammad R Akbari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Triple-negative breast cancer: clinical features and patterns of recurrenceRebecca Dent, Maureen Trudeau, Kathleen I Pritchard, et al.
Hereditary Cancer in Clinical Practice|October 5, 2020
Preferences for breast cancer prevention among women with a <i>BRCA1</i> or <i>BRCA2</i> mutationCarol A Mansfield, Kelly A Metcalfe, Carrie Snyder, et al.
Breast Cancer Research : BCR|July 24, 2012
Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancerTomasz Byrski, Rebecca Dent, Pawel Blecharz, et al.
Iscience|July 12, 2024
A high-throughput approach to identify BRCA1-downregulating compounds to enhance PARP inhibitor sensitivityErin Sellars, Margarita Savguira, Jie Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
Assessing individual risk for prostate cancerRobert K Nam, Ants Toi, Laurence H Klotz, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|December 3, 2009
The rs1447295 and DG8S737 markers on chromosome 8q24 and cancer risk in the Polish populationDominika Wokołorczyk, Bartomiej Gliniewicz, Marcin Stojewski, et al.
Breast Cancer Research and Treatment|December 17, 2017
Predictors of survival for breast cancer patients with a BRCA1 mutationSteven A Narod, Tomasz Huzarski, Jacek Gronwald, et al.
The Lancet. Oncology|January 21, 2014
Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort studyRobert K Nam, Patrick Cheung, Sender Herschorn, et al.
Pageof 55

Showing results (261-270 of 544) with videos related to

Sort By:
Pageof 55
Breast Cancer Research and Treatment|November 26, 2008
Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer riskPablo Serrano-Fernández, Tadeusz Debniak, Bohdan Górski, et al.
Plos One|June 16, 2009
Polymorphic variation of genes in the fibrinolytic system and the risk of ovarian cancerYaakov Bentov, Theodore J Brown, Mohammad R Akbari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Triple-negative breast cancer: clinical features and patterns of recurrenceRebecca Dent, Maureen Trudeau, Kathleen I Pritchard, et al.
Hereditary Cancer in Clinical Practice|October 5, 2020
Preferences for breast cancer prevention among women with a <i>BRCA1</i> or <i>BRCA2</i> mutationCarol A Mansfield, Kelly A Metcalfe, Carrie Snyder, et al.
Breast Cancer Research : BCR|July 24, 2012
Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancerTomasz Byrski, Rebecca Dent, Pawel Blecharz, et al.
Iscience|July 12, 2024
A high-throughput approach to identify BRCA1-downregulating compounds to enhance PARP inhibitor sensitivityErin Sellars, Margarita Savguira, Jie Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
Assessing individual risk for prostate cancerRobert K Nam, Ants Toi, Laurence H Klotz, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|December 3, 2009
The rs1447295 and DG8S737 markers on chromosome 8q24 and cancer risk in the Polish populationDominika Wokołorczyk, Bartomiej Gliniewicz, Marcin Stojewski, et al.
Breast Cancer Research and Treatment|December 17, 2017
Predictors of survival for breast cancer patients with a BRCA1 mutationSteven A Narod, Tomasz Huzarski, Jacek Gronwald, et al.
The Lancet. Oncology|January 21, 2014
Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort studyRobert K Nam, Patrick Cheung, Sender Herschorn, et al.
Pageof 55